Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate in Children with Idiopathic Juvenile Osteoporosis
NCT00010439Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Sep 2000
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of alendronate in idiopathic juvenile osteoporosis (IJO), sponsored by Medical University of South Carolina. Primary endpoint: Number of Participants With Increased Bone Mineral Density at 12 months. Started Sep 2000; status: completed.
02
Drugs
alendronate
03
Conditions
idiopathic juvenile osteoporosis (IJO)
Beyond the preview
Go deeper on NCT00010439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010439.